scholarly journals Single-cell transfection technologies for cell therapies and gene editing

Author(s):  
Bastien Duckert ◽  
Steven Vinkx ◽  
Dries Braeken ◽  
Maarten Fauvart
2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Yu Ting Chow ◽  
Shuxun Chen ◽  
Ran Wang ◽  
Chichi Liu ◽  
Chi-wing Kong ◽  
...  

2018 ◽  
Vol 15 (2) ◽  
pp. 63-64 ◽  
Author(s):  
Parker C. Wilson ◽  
Benjamin D. Humphreys

2019 ◽  
Vol 37 (12) ◽  
pp. 1425-1434 ◽  
Author(s):  
Stefanie R. Bailey ◽  
Marcela V. Maus

2013 ◽  
Vol 7 (10) ◽  
pp. 762-762
Author(s):  
Rachel Won

2021 ◽  
Vol 8 ◽  
Author(s):  
Bolun Li ◽  
Xiaomin Song ◽  
Wenjun Guo ◽  
Yangfeng Hou ◽  
Huiyuan Hu ◽  
...  

Abdominal aortic aneurysm (AAA) is potentially life-threatening in aging population due to the risk of aortic rupture and a lack of optimal treatment. The roles of different vascular and immune cells in AAA formation and pathogenesis remain to be future characterized. Single-cell RNA sequencing was performed on an angiotensin (Ang) II-induced mouse model of AAA. Macrophages, B cells, T cells, fibroblasts, smooth muscle cells and endothelial cells were identified through bioinformatic analyses. The discovery of multiple subtypes of macrophages, such as the re-polarization of Trem2+Acp5+ osteoclast-like and M2-like macrophages toward the M1 type macrophages, indicates the heterogenous nature of macrophages during AAA development. More interestingly, we defined CD45+COL1+ fibrocytes, which was further validated by flow cytometry and immunostaining in mouse and human AAA tissues. We then reconstituted these fibrocytes into mice with Ang II-induced AAA and found the recruitment of these fibrocytes in mouse AAA. More importantly, the fibrocyte treatment exhibited a protective effect against AAA development, perhaps through modulating extracellular matrix production and thus enhancing aortic stability. Our study reveals the heterogeneity of macrophages and the involvement of a novel cell type, fibrocyte, in AAA. Fibrocyte may represent a potential cell therapy target for AAA.


2014 ◽  
Author(s):  
Yoshihiko Arita ◽  
Martin Ploschner ◽  
Maciej Antkowiak ◽  
Frank Gunn-Moore ◽  
Kishan Dholakia

Science ◽  
2019 ◽  
Vol 365 (6460) ◽  
pp. 1401-1405 ◽  
Author(s):  
J. Gray Camp ◽  
Randall Platt ◽  
Barbara Treutlein

The cumulative activity of all of the body’s cells, with their myriad interactions, life histories, and environmental experiences, gives rise to a condition that is distinctly human and specific to each individual. It is an enduring goal to catalog our human cell types, to understand how they develop, how they vary between individuals, and how they fail in disease. Single-cell genomics has revolutionized this endeavor because sequencing-based methods provide a means to quantitatively annotate cell states on the basis of high-information content and high-throughput measurements. Together with advances in stem cell biology and gene editing, we are in the midst of a fascinating journey to understand the cellular phenotypes that compose human bodies and how the human genome is used to build and maintain each cell. Here, we will review recent advances into how single-cell genomics is being used to develop personalized phenotyping strategies that cross subcellular, cellular, and tissue scales to link our genome to our cumulative cellular phenotypes.


2009 ◽  
Vol 81 (10) ◽  
pp. 4060-4067 ◽  
Author(s):  
Manyan Wang ◽  
Owe Orwar ◽  
Stephen G. Weber

Sign in / Sign up

Export Citation Format

Share Document